UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 5 von 23991
Datensatz exportieren als...
BibTeX
Psychometric validation of the female sexual function index (FSFI) in cancer survivors
Cancer, 2012-09, Vol.118 (18), p.4606-4618
Baser, Raymond E.
Li, Yuelin
Carter, Jeanne
2012
Details
Autor(en) / Beteiligte
Baser, Raymond E.
Li, Yuelin
Carter, Jeanne
Titel
Psychometric validation of the female sexual function index (FSFI) in cancer survivors
Ist Teil von
Cancer, 2012-09, Vol.118 (18), p.4606-4618
Ort / Verlag
Hoboken: Wiley Subscription Services, Inc., A Wiley Company
Erscheinungsjahr
2012
Link zum Volltext
Quelle
MEDLINE
Beschreibungen/Notizen
BACKGROUND: The Female Sexual Function Index (FSFI) is the most commonly used self‐report instrument to measure sexual functioning among women cancer survivors. Despite this, the validity and reliability of the FSFI for use in cancer populations has not been established. METHODS: Data were combined from 3 separate institutional review board‐approved studies of the psychosexual adjustment of women cancer survivors conducted at Memorial Sloan‐Kettering Cancer Center. Psychometric analysis was applied to the FSFI responses from 181 women comprising 4 cohorts, including survivors of: gynecologic cancer (all types; 2 cohorts), malignancies requiring bone‐marrow/stem cell transplantation, and early stage cervical cancer. RESULTS: A factor analysis supported the subscale structure of the FSFI, yielding results nearly identical to those from the original FSFI validation study. Internal consistency reliability was 0.94 for the FSFI total score and ranged from 0.85 to 0.94 for the domain scores. Corrected item‐total correlations ranged from 0.44 to 0.79 for the total score and from 0.62 to 0.88 for the domain scores. FSFI scores were correlated negatively with measures of depression, distress, and menopausal symptoms and were correlated positively with quality of life. FSFI scores exhibited a preliminary ability to discriminate between women based on whether or not they received chemotherapy and/or radiation. CONCLUSIONS: The FSFI demonstrated strong psychometric properties in this study, supporting its continued use for monitoring sexual function and cancer‐related dysfunction among sexually active women who are cancer survivors. Cancer 2012. © 2012 American Cancer Society. The Female Sexual Function Index (FSFI) displays strong psychometric reliability and validity in this first validation of the instrument in cancer survivors. The results support its continued use for monitoring sexual function and cancer‐related dysfunction among sexually active female cancer survivors.
Sprache
Englisch
Identifikatoren
ISSN: 0008-543X
eISSN: 1097-0142
DOI: 10.1002/cncr.26739
Titel-ID: cdi_proquest_miscellaneous_1038607109
Format
–
Schlagworte
Adult
,
Biological and medical sciences
,
Female
,
Genital Neoplasms, Female - psychology
,
Genital Neoplasms, Female - therapy
,
Humans
,
Medical sciences
,
physiological
,
psychological
,
Psychometrics
,
quality of life
,
questionnaires
,
self‐report
,
sexual dysfunctions
,
Sexual Dysfunctions, Psychological
,
Surveys and Questionnaires
,
Survivors
,
Tumors
,
women
,
Women's Health
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX